Stevanato Group to Present at Upcoming Investor Conference
Stevanato Group (NYSE: STVN), a global leader in drug containment and delivery solutions for pharmaceutical, biotechnology, and life sciences industries, has announced its participation in the CJS Securities 25th Annual "New Ideas for the New Year" Investor Conference. The presentation is scheduled for Tuesday, January 14, 2025, at 8:00 a.m. ET.
The company will provide a live webcast of the event through their website at www.stevanatogroup.com in the "Investors" section. Interested parties who cannot attend the live presentation can access a replay of the webcast, which will remain available for approximately 90 days following the event.
Stevanato Group (NYSE: STVN), leader globale nelle soluzioni di contenimento e somministrazione dei farmaci per le industrie farmaceutiche, biotecnologiche e delle scienze della vita, ha annunciato la sua partecipazione alla 25ª Conferenza Annuale di Investitori
Stevanato Group (NYSE: STVN), líder global en soluciones de contención y entrega de medicamentos para las industrias farmacéutica, biotecnológica y de ciencias de la vida, ha anunciado su participación en la 25ª Conferencia Anual de Inversores
Stevanato Group (NYSE: STVN)는 제약, 생명공학 및 생명 과학 산업을 위한 약물 저장 및 전달 솔루션의 글로벌 리더로, CJS Securities 제25회 연례
Stevanato Group (NYSE: STVN), leader mondial des solutions de confinement et de distribution de médicaments pour les industries pharmaceutiques, biotechnologiques et des sciences de la vie, a annoncé sa participation à la 25e Conférence Annuelle des Investisseurs
Stevanato Group (NYSE: STVN), ein weltweit führendes Unternehmen für Arzneimittelcontainment und -abgabe-Lösungen in der Pharma-, Biotechnologie- und Lebenswissenschaftsbranche, hat seine Teilnahme an der 25. jährlichen Investorenkonferenz
- None.
- None.
PIOMBINO DESE,
A live event webcast will be available on the Company’s website at www.stevanatogroup.com under the "Investors" section. A replay of the webcast will be available for approximately 90 days after the event.
About Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle at each of the development, clinical, and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation, and its engineering excellence are central to its ability to offer value-added solutions to clients. To learn more, visit: www.stevanatogroup.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250107770594/en/
Media
Stevanato Group
media@stevanatogroup.com
Investor Relations
Lisa Miles
lisa.miles@stevanatogroup.com
Source: Stevanato Group
FAQ
When is Stevanato Group (STVN) presenting at the CJS Securities Conference 2025?
How can investors watch Stevanato Group's (STVN) CJS Securities Conference presentation?
How long will the replay of STVN's CJS Securities Conference presentation be available?
Which investor conference is Stevanato Group (STVN) participating in January 2025?
